Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine
Respiratory syncytial virus (RSV) infection is a severe threat to young children and the elderly. Despite decades of research, no vaccine has been approved. Notably, instead of affording protection, a formalin-inactivated RSV vaccine induced severe respiratory disease including deaths in vaccinated...
Main Authors: | Marsha S. Russell, Marybeth Creskey, Abenaya Muralidharan, Changgui Li, Jun Gao, Wangxue Chen, Louise Larocque, Jessie R. Lavoie, Aaron Farnsworth, Michael Rosu-Myles, Anwar M. Hashem, Carole L. Yauk, Jingxin Cao, Gary Van Domselaar, Terry Cyr, Xuguang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00597/full |
Similar Items
-
Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies
by: Abenaya Muralidharan, et al.
Published: (2017-04-01) -
Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians
by: Matteo Riccò, et al.
Published: (2023-02-01) -
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
by: Sathya N. Thulasi Raman, et al.
Published: (2023-12-01) -
All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?
by: Sofie Schaerlaekens, et al.
Published: (2024-01-01) -
Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
by: Carlotta Biagi, et al.
Published: (2020-11-01)